Age does not adversely influence outcomes among patients older than 60 years who undergo allogeneic hematopoietic stem cell transplant for AML and myelodysplastic syndrome
暂无分享,去创建一个
A. Deol | J. Uberti | V. Ratanatharathorn | A. Alavi | S. Kim | D. Modi | D. Bhutani | M. Ventimiglia | L. Ayash